{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T14:07:58Z","timestamp":1793196478343,"version":"4.5.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,30]],"date-time":"2023-06-30T00:00:00Z","timestamp":1688083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,30]],"date-time":"2023-06-30T00:00:00Z","timestamp":1688083200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Egypt Heart J"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Patients with hypertrophic cardiomyopathy may develop symptoms of shortness of breathing due to diastolic dysfunction which is not related to the severity of left ventricular outflow tract obstruction. As these patients usually develop a non-ischemic pattern of myocardial fibrosis, this may represent a mechanism for increased myocardial stiffness leading to impaired diastolic filling. The study aimed to determine the prevalence of myocardial fibrosis assessed by magnetic resonance imaging in children with hypertrophic cardiomyopathy and to evaluate its relationship with echocardiographic parameters including left ventricle diastolic dysfunction and to find echocardiographic indices which correlates with myocardial fibrosis as detected by cardiac magnetic resonance. A cross-sectional study was done for data of 50 children with hypertrophic cardiomyopathy from July 2018 to July 2021, patients were divided into (group 1) having myocardial fibrosis and (group 2) with no myocardial fibrosis, and results of echocardiographic parameters were compared between the two groups.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Results showed strong relationship between presence of myocardial fibrosis and each of the following: Interventricular septum thickness, lower lateral and septal early diastolic tissue velocities (<jats:italic>E<\/jats:italic>\u2032), <jats:italic>E<\/jats:italic>\/<jats:italic>E<\/jats:italic>\u2032 ratio, presence of left ventricular out flow tract obstruction and the grade of diastolic dysfunction.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The trans-mitral lateral and septal <jats:italic>E<\/jats:italic>\/<jats:italic>E<\/jats:italic>\u2032 (early mitral inflow to early diastolic mitral annular velocity ratio) allows early detection of left ventricular diastolic dysfunction in children with hypertrophic cardiomyopathy. The prevalence of diastolic dysfunction is higher in obstructive hypertrophic cardiomyopathy. The diastolic dysfunction severity is higher in patients with myocardial fibrosis.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s43044-023-00382-1","type":"journal-article","created":{"date-parts":[[2023,6,30]],"date-time":"2023-06-30T07:02:09Z","timestamp":1688108529000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Evaluation of diastolic dysfunction in children with hypertrophic cardiomyopathy and its relationship with development of myocardial fibrosis"],"prefix":"10.1186","volume":"75","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7398-3579","authenticated-orcid":false,"given":"Salem Elsayed","family":"Deraz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar Deyaa","family":"Esmat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rehab Galal Abd","family":"El-Hmid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayed Ali","family":"Amin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,30]]},"reference":[{"key":"382_CR1","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1056\/NEJMoa021715","volume":"348","author":"SE Lipshultz","year":"2003","unstructured":"Lipshultz SE, Sleeper LA, Towbin JA et al (2003) The incidence of pediatric cardiomyopathy in two regions of the United States. N Eng J Med 348:1647\u20131655","journal-title":"N Eng J Med"},{"key":"382_CR2","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1016\/j.pcl.2004.04.017","volume":"51","author":"BJ Maron","year":"2004","unstructured":"Maron BJ (2004) Hypertrophic cardiomyopathy in childhood. Paediatr Clin North Am 51:1305\u20131334","journal-title":"Paediatr Clin North Am"},{"key":"382_CR3","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1161\/CIRCULATIONAHA.104.530303","volume":"112","author":"A Nugent","year":"2005","unstructured":"Nugent A, Daubeney P, Chondros P et al (2005) Clinical features and outcomes of childhood hypertrophic cardiomyopathy: results from a national population-based study. Circulation 112:1332\u20131338","journal-title":"Circulation"},{"key":"382_CR4","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1161\/CIRCULATIONAHA.107.694158","volume":"117","author":"MA Fifer","year":"2008","unstructured":"Fifer MA, Vlahakes GJ (2008) Management of symptoms in hypertrophic cardiomyopathy. Circulation 117:429\u2013439","journal-title":"Circulation"},{"key":"382_CR5","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1136\/heart.84.5.476","volume":"84","author":"AM Varnava","year":"2000","unstructured":"Varnava AM, Elliott PM, Sharma S, McKenna WJ, Davies MJ (2000) Hypertrophic cardiomyopathy: the interrelation of disarray, fibrosis, and small vessel disease. Heart 84:476\u2013482","journal-title":"Heart"},{"key":"382_CR6","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/j.jacc.2010.11.013","volume":"57","author":"N Mewton","year":"2011","unstructured":"Mewton N, Liu CY, Croisille P, Bluemke D, Lima JA (2011) Assessment of myocardial fibrosis with cardiovascular magnetic resonance. J Am Coll Cardiol 57:891\u2013903","journal-title":"J Am Coll Cardiol"},{"key":"382_CR7","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1016\/j.jacc.2010.05.010","volume":"56","author":"R O\u2019Hanlon","year":"2010","unstructured":"O\u2019Hanlon R, Grasso A, Roughton M et al (2010) Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy. J Am Coll Cardiol 56:867\u2013874","journal-title":"J Am Coll Cardiol"},{"key":"382_CR8","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1161\/01.CIR.104.2.128","volume":"104","author":"SF Nagueh","year":"2001","unstructured":"Nagueh SF, Bachinski LL, Meyer D et al (2001) Tissue Doppler imaging consistently detects myocardial abnormalities in patients with hypertrophic cardiomyopathy and provides a novel means for an early diagnosis before and independently of hypertrophy. Circulation 104:128\u2013130","journal-title":"Circulation"},{"key":"382_CR9","doi-asserted-by":"publisher","first-page":"2733","DOI":"10.1093\/eurheartj\/ehu284","volume":"35","author":"PM Elliott","year":"2014","unstructured":"Elliott PM, Anastasakis A, Borger MA et al (2014) ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy. The Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). Eur Heart J 35:2733\u201379","journal-title":"Eur Heart J"},{"issue":"4","key":"382_CR10","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/1749-8090-4-34","volume":"15","author":"EE Apostolakis","year":"2009","unstructured":"Apostolakis EE, Baikoussis NG (2009) Methods of estimation of mitral valve regurgitation for the cardiac surgeon. J Cardiothorac Surg 15(4):34","journal-title":"J Cardiothorac Surg"},{"key":"382_CR11","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.echo.2016.01.011","volume":"29","author":"SF Nagueh","year":"2016","unstructured":"Nagueh SF, Smiseth OA, Appleton CP et al (2016) Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 29:277\u2013314","journal-title":"J Am Soc Echocardiogr"},{"issue":"2","key":"382_CR12","doi-asserted-by":"publisher","first-page":"328","DOI":"10.5114\/aoms.2016.60404","volume":"13","author":"L Ziolkowska","year":"2017","unstructured":"Ziolkowska L, Petryka J, Boruc A, Kawalec W (2017) comparison of echocardiography with tissue Doppler imaging and magnetic resonance imaging with delayed encahncement in assessment of children with hypertrophic cardiomyopathy. Arch Med Sci 13(2):328\u2013336","journal-title":"Arch Med Sci"},{"key":"382_CR13","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1161\/CIRCHEARTFAILURE.109.854026","volume":"3","author":"R Rubinshtein","year":"2010","unstructured":"Rubinshtein R, Glockner JF, Ommen SR et al (2010) Characteristics and clinical significance of late gadolinium enhancement by contrast-enhanced magnetic resonance imaging in patients with hypertrophic cardiomyopathy. Cir Heart Fail 3:51\u201358","journal-title":"Cir Heart Fail"},{"key":"382_CR14","doi-asserted-by":"publisher","first-page":"2156","DOI":"10.1016\/S0735-1097(02)02602-5","volume":"40","author":"L Choudhury","year":"2002","unstructured":"Choudhury L, Mahrholdt H, Wagner A et al (2002) Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 40:2156\u20132164","journal-title":"J Am Coll Cardiol"},{"key":"382_CR15","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1161\/CIRCHEARTFAILURE.108.768119","volume":"1","author":"MS Maron","year":"2008","unstructured":"Maron MS, Appelbaum E, Harrigan CJ et al (2008) Clinical profile and significance of delayed enhancement in hypertrophic cardiomyopathy. Circ Heart Fail 1:184\u2013191","journal-title":"Circ Heart Fail"},{"key":"382_CR16","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1161\/CIRCIMAGING.108.838367","volume":"2","author":"A Moreo","year":"2009","unstructured":"Moreo A, Ambrosio G, De Chiara B et al (2009) Influence of myocardial fibrosis on left ventricular diastolic function noninvasive assessment by cardiac magnetic resonance and echo. Circ Cardiovasc Imaging 2:437\u2013443","journal-title":"Circ Cardiovasc Imaging"},{"key":"382_CR17","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/1532-429X-14-76","volume":"14","author":"AH Ellims","year":"2012","unstructured":"Ellims AH, Iles LM, Ling LH, Hare JL, Kaye DM, Taylor AJ (2012) Diffuse myocardial fibrosis in hypertrophic cardiomyopathy can be identified by cardiovascular magnetic resonance and is associated with left ventricular diastolic dysfunction. J Cardiovasc Magn Reson 14:64\u201376","journal-title":"J Cardiovasc Magn Reson"}],"container-title":["The Egyptian Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43044-023-00382-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s43044-023-00382-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43044-023-00382-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,30]],"date-time":"2023-06-30T07:02:52Z","timestamp":1688108572000},"score":1,"resource":{"primary":{"URL":"https:\/\/tehj.springeropen.com\/articles\/10.1186\/s43044-023-00382-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,30]]},"references-count":17,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["382"],"URL":"https:\/\/doi.org\/10.1186\/s43044-023-00382-1","relation":{},"ISSN":["2090-911X"],"issn-type":[{"value":"2090-911X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,30]]},"assertion":[{"value":"2 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare review and approval of the study by Aswan Heart Centre as well as faculty of medicine, Fayoum university research ethical committees. Freely given, informed, written consent to participate in the study was obtained from participants parents. Participants were informed about the objectives of the study. Committee\u2019s reference number: not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"54"}}